D47.09 Other mast cell neoplasms of uncertain behavior

✓ Billable ICD-10-CM 2026
Open D47.09 in Web App →

The ICD-10-CM code for Other mast cell neoplasms of uncertain behavior is D47.09 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
D37-D48: Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)
Category D47
14 codes (11 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to D47.09:

  • Mastocytosis
  • Mastocytoma (extracutaneous)
  • Mast cell › tumor
  • Neoplasm, neoplastic › mast cell, of uncertain behavior NEC
  • Tumor › mast cell
  • Mast cell › neoplasm › of uncertain behavior NEC

Inclusion Terms

  • Extracutaneous mastocytoma
  • Mast cell tumor NOS
  • Mastocytoma NOS
  • Mastocytosis NOS

U.S. Hospital Utilization

  • An estimated 635 U.S. inpatient stays in 2023 included D47.09 among the documented diagnoses.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial